Gastroesophageal reflux disease and baclofen: Is there a light at the end of the tunnel?

Current Gastroenterology Reports

Volumn 6, Issue 3, 2004, Pages 213-219

  Wise, James ^b   Conklin, Jeffrey L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID DERIVATIVE; ACID; ATROPINE; BACLOFEN; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; GLUTAMIC ACID; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;

CLINICAL TRIAL; CONFUSION; DIZZINESS; DROWSINESS; DRUG MECHANISM; DRUG TOLERABILITY; ESOPHAGITIS; GASTROINTESTINAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MUSCLE WEAKNESS; NAUSEA; NONHUMAN; REVIEW; SIDE EFFECT; SMOOTH MUSCLE RELAXATION; SOMNOLENCE; STOMACH DISTENSION; SWALLOWING; SYMPTOMATOLOGY; VAGUS REFLEX; ANIMAL; DRUG EFFECT; GASTROESOPHAGEAL REFLUX; MANOMETRY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX; VAGUS NERVE;

ANIMALS; BACLOFEN; ESOPHAGOGASTRIC JUNCTION; GABA AGONISTS; GASTROESOPHAGEAL REFLUX; HUMANS; MANOMETRY; REFLEX; VAGUS NERVE;

EID: 4544220343     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0010-9     Document Type: Review

References (47)

1. Trifan A, Shaker R, Ren J, et al.: Inhibition of resting lower esophageal sphincter pressure by pharyngeal water stimulation in humans. Gastroenterology 1995, 108: 441-446.
2. Noordzij JP, Mittal RK, Arora T, et al.: The effect of mechanoreceptor stimulation of the laryngopharynx on the oesophago-gastric junction. Neurogastroenterol Motil 2000, 12: 353-359.
3. Dent J, Dodds WJ, Hogan WJ, Toouli J: Factors that influence induction of gastroesophageal reflux in normal human subjects Dig Dis Sci 1988, 33: 270-275.
4. Xie P-Y, Barden E, Ren J, et al.: Esophageal distention: an unsuspected trigger mechanism for gastroesophageal reflux. J Beijing Med Univ 2000, 32: 121-122.
5. Mittal RK, Holloway RH, Penagini R, et al.: Transient lower esophageal sphincter relaxation. Gastroenterology 1995, 109: 601-610.
6. Martin CJ, Patrikios J, Dent J: Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog. Gastroenterology 1986, 81: 890-896.
7. Franzi SJ, Martin CJ, Cox MR, Dent J: Response of canine lower esophageal sphincter to gastric distention. Am J Physiol 1990, 259: G380-G385.
8. Smith BN, Dou P, Barber WD, Dudek FE: Vagally evoked synaptic currents in the immature rat nucleus tractus solitarii in an intact in vitro preparation. J Physiol 1998, 512: 149-162.
9. Abrahams TP, Partosoedarso ER, Hornby PJ: Lower esophageal sphincter relaxation evoked by stimulation of the dorsal motor nucleus of the vagus in ferrets. Neurogastroenterol Motil 2002, 14: 295-304.
10. McDermott CM, Abrahams TP, Partosoedarso ER, et al.: Site of action of GABAB receptor for vagal motor control of lower esophageal sphincter in ferrets and rats. Gastroenterology 2001, 120: 1749-1762.
11. Barone FC, Lombardi DM, Ormsbee HIS: Effect of hindbrain stimulation on lower esophageal sphincter pressure in cats. Am J Physiol 1984, 217: G70-G78.
12. Boyle JT, Altschuler SM, Nixon TE, et al.: Response of feline gastroesophageal junction to changes in abdominal pressure. Am J Physiol 1987, 253: G315-G322.
13. Fang JC, Sarosiek I, Yamamoto Y, et al.: Cholinergic blockade inhibits gastroesophageal reflux and transient lower esophageal sphincter relaxation through a central mechanism. Gut 1998, 115: 1374-1380.
14. Murray J, Du C, Ledlow A, et al.: Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol 1991, 261: G401-G406.
15. Tottrup A, Svane D, Forman A: Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am J Physiol 1991, 260: G385-G389.
16. Biancani P, Walsh JH, Behar J: Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter. J Clin Invest 1984, 73: 963-967.
17. Ong J, Kerr DI: Recent advances in GABAB receptors: from pharmacology to molecular biology. Acta Pharmacol Sin 2000, 21: 111-123.
18. Smid DS, Young RL, Cooper NJ, Blackshaw LA: GABA(B)R expressed on vagal afferent neurons inhibit gastric mechanosensitivity in ferret proximal stomach. Am J Physiol 2001, 281: G1494-G1501.
19. Zagorodnyuk VP, D'Antona G, Brooks SJ, Costa M: Functional GABAB receptors are present on the guinea pig nodose ganglion cell bodies but not in peripheral mechanosensitive ends. Auton Neurosci 2002, 102: 20-29.
20. Partosoedarso ER, Young RL, Blackshaw LA: GABAB receptors on vagal afferent pathways: peripheral and central inhibition. Am J Physiol 2001, 280: G658-G668.
21. Page AJ, Blackshaw LA: GABAB receptors inhibit mechanosensitivity of primary afferent endings. J Neurosci 1999, 19: 8597-8602.
22. Brooks PA, Glaum SR, Miller RJ, Spyer KM: The actions of baclofen on neurons and synaptic transmission in the nucleus tractus solitarii of the rat in vitro. J Physiol 1992, 457: 115-129.
23. Browning KN, Travagli RA: Mechanism of action of baclofen in rat dorsal motor nucleus of the vagus. Am J Physiol 2001, 280: G1106-G1113.
24. Smid DS, Blackshaw LA: Vagal transmission to the ferret lower oesophageal sphincter: inhibition by GABA(B) receptors. Br J Pharmacol 2000, 131: 624-630.
25. Kilbinger H, Ginap T, Erbelding D: GABAergic inhibition of nitric oxide-mediated relaxation of guinea pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1999, 359: 500-504.
26. Patrikios J, Martin CJ, Dent J: Relationship of transient lower esophageal sphincter relaxation to postprandial gastroesophageal reflux and belching in dogs. Gastroenterology 1986, 90: 545-551.
27. Lehmann A, Antonsson M, Bremer-Danielsen M, et al.: Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs. Gastroenterology 1999, 117: 1147-1154.
28. Lehmann A, Bremer-Danielsen M, Braden L, Karrberg L: Inhibitory effects of GABA(B) receptor agonists on swallowing in the dog. Eur J Pharmacol 2002, 448: 67-70.
29. Blackshaw LA, Staunton D, Dent J, et al.: Mechanisms of gastro-oesophageal reflux in the ferret. Neurogastroenterol Motil 1998, 10: 49-56.
30. Blackshaw LA, Staunton D, Lehmann A, Dent J: Inhibition of transient LES relaxations and reflux by GABA receptor agonists. Am J Physiol 1999, 277: G867-G874.
31. Liu J, Pehlivanova N, Mittal RK: Baclofen blocks LES relaxation and crural diaphragm inhibition by esophageal and gastric distention in cats. Am J Physiol 2002, 283: G1276-GI281.
32. Dodds WJ, Dent J, Hogan WJ, et al.: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Eng J Med 1982, 301: 1547-1552.
33. Mittal RK, Holloway R, Dent J: Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 1995, 109: 1547-1554.
34. Mittal RK, Chiareli C, Liu J, et al.: Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation. Gut 1997, 41: 285-290.
35. Penagini R, Bianchi PA: Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology 1997, 113: 409-414.
36. Hirsch DP, Tytgat GN, Boeckxstaens GE: Is glutamate involved in transient lower esophageal sphincter relaxations? Dig Dis Sci 2002, 47: 661-666.
37. Boeckxstaens GE, Hirsch DP, Fakhry N, et al.: Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. Am J Gastroenterol 1998, 93: 1823-1828.
38. Hirsh DP, Tiel-Van Buul MM, Tytgat GN, Boeckxstaens GE: Effect of L-NMMA on postprandial transient lower esophageal sphincter relaxations in healthy volunteers. Dig Dis Sci 2000, 45: 2069-2075.
39. Lidums I, Lehmann A, Checklin H, et al.: Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000, 118: 7-13.
40. Zhang Q, Lehmann A, Rigda R, et al.: Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002, 50: 19-24.
41. van Herwaarden MA, Samsom M, Rydholm H, Smout AJ: The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther 2002, 16: 1655-1662.
42. Vela MF, Tutuian R, Katz PO, Castell DO: Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003, 17: 243-251.
43. Cange L, Johnsson E, Rydholm H, et al.: Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Aliment Pharmacol Ther 2002, 16: 869-873.
44. Ciccaglione AF, Marzio L: Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003, 52: 464-470.
45. Cossentino MJ, Maydonovitch C, Belle L, Wong RKH: Effects of baclofen on patients with gastroesophageal reflux disease: a prospective randomized, double-blinded, placebo-controlled study [abstract]. Gastroenterology 2003, 124(Suppl 1): A226.
46. Koek GH, Sifrim D, Lerut T, et al.: Effect of the GABA(B) agonist baclofen in patients with symptoms and duodenogastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003, 52: 1397-1402.
47. Lioresal (Novanis). In Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997:847-848.